FDA APPROVES SPIRUS MEDICAL'S ENDO-EASE DEVICE
The FDA has granted Spirus Medical 510(k) clearance for its Endo-Ease Endoluminal Advancement System. Endo-Ease is a device that uses rotation to allow doctors to undertake gastrointestinal endoscopy in a "gentler, easier and more efficient" manner, the company says.
The company has also received $5.9 million in preferred equity financing for the device. BioVentures Investors, Point Judith Capital and Village Ventures, along with a group of accredited individual investors, participated in the financing and Boston Equity Advisors, LLC served as placement agent for the offering.
"This funding provides us with the resources to begin manufacturing and commercialization of the Endo-Ease product line later this year," said Ross Garofalo, Spirus chief financial officer.
Upcoming Events
-
14May
-
23May
-
30May
-
20Jun
-
21Oct